Financial Performance - The company's revenue for Q3 2023 was ¥1,134,556,200.95, representing a decrease of 6.33% compared to the same period last year[4]. - The net profit attributable to shareholders for Q3 2023 was ¥355,047,363.97, down 2.82% year-on-year[4]. - The basic earnings per share for Q3 2023 was ¥0.61, a decrease of 3.17% compared to the same period last year[5]. - Total operating revenue for the first three quarters of 2023 was ¥3,242,497,407.54, a slight decrease from ¥3,281,481,000.43 in the same period of 2022, representing a decline of approximately 1.18%[18]. - Total operating costs for the first three quarters of 2023 were ¥2,326,702,156.56, down from ¥2,377,505,303.69 in 2022, indicating a decrease of about 2.12%[18]. - Net profit for the third quarter of 2023 was ¥915,410,745.17, compared to ¥915,428,909.15 in the same quarter of 2022, showing a marginal decrease of 0.002%[19]. - The total comprehensive income for the third quarter of 2023 was ¥915,998,287.10, slightly down from ¥916,703,080.59 in the same quarter of 2022[20]. Assets and Liabilities - The total assets at the end of Q3 2023 amounted to ¥11,072,219,908.39, an increase of 5.73% from the end of the previous year[5]. - The company's total liabilities reached ¥2,714,260,377.35, up from ¥2,560,138,484.97, which is an increase of about 6.0%[16]. - The company's total assets and shareholders' equity as of the end of the third quarter of 2023 were ¥11,072,219,908.39 and ¥8,357,959,531.04, respectively, compared to ¥10,472,319,073.02 and ¥7,912,180,588.05 in the previous year[17]. - The company's cash and cash equivalents decreased to RMB 443,065,646.47 from RMB 1,137,621,764.53, reflecting a decline of about 61.0%[13]. - Accounts receivable increased to RMB 1,109,622,391.82 from RMB 1,052,439,134.18, showing a growth of approximately 5.4%[13]. - The company's inventory stood at RMB 748,795,765.35, slightly down from RMB 752,303,140.17, indicating a decrease of about 0.5%[15]. - Total current liabilities increased to RMB 2,271,767,026.04 from RMB 2,166,856,343.92, marking an increase of approximately 4.8%[16]. - The company reported a significant increase in other current assets, which rose to RMB 3,934,718,129.98 from RMB 3,184,609,065.62, reflecting a growth of approximately 23.5%[15]. - The company’s long-term equity investments decreased to RMB 8,195,509.00 from RMB 10,755,004.86, a decline of about 23.7%[15]. - The company’s non-current assets totaled RMB 4,691,691,677.99, an increase from RMB 4,218,771,371.55, representing a growth of approximately 11.2%[15]. - The company’s total equity remained stable at RMB 4,100,916,401.24, unchanged from the previous reporting period[16]. Cash Flow - The cash flow from operating activities for the year-to-date was ¥951,113,025.41, reflecting a decrease of 5.69%[5]. - Cash flow from operating activities for the first three quarters of 2023 was ¥3,487,002,862.64, compared to ¥3,464,806,882.08 in the same period of 2022, indicating an increase of approximately 0.64%[21]. - Net cash flow from operating activities for Q3 2023 was ¥951,113,025.41, a decrease of 5.7% compared to ¥1,008,547,134.85 in Q3 2022[22]. - Total cash inflow from financing activities was ¥1,012,000,000.00, an increase of 26.4% from ¥801,000,000.00 in the same period last year[23]. - Cash outflow from investing activities totaled ¥1,599,897,102.58, down 43.5% from ¥2,831,898,507.03 in Q3 2022[22]. - Cash and cash equivalents at the end of Q3 2023 were ¥442,045,146.47, a decrease from ¥849,350,675.04 at the end of Q3 2022[23]. - The company received cash from other operating activities amounting to ¥96,474,518.61, down 27.6% from ¥133,234,117.54 in Q3 2022[22]. - Cash paid to employees increased to ¥852,863,771.00, up 14.2% from ¥746,670,373.16 in the previous year[22]. - Cash flow from investment activities showed a net outflow of ¥1,457,441,784.66, compared to a net outflow of ¥855,683,891.09 in Q3 2022[22]. - The company reported cash inflow from the disposal of fixed assets of ¥277,000.00, an increase from ¥200,300.00 in the same quarter last year[22]. - Cash flow from financing activities showed a net outflow of ¥191,706,034.07, compared to a net outflow of ¥75,024,124.23 in Q3 2022[23]. - The impact of exchange rate changes on cash and cash equivalents was ¥3,478,675.26, compared to ¥4,116,399.23 in Q3 2022[23]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 29,698[8]. - The largest shareholder, Zhengzhou Antu Industrial Group Co., Ltd., holds 323,879,773 shares, accounting for 55.24% of the total shares[9]. Research and Development - Research and development expenses for the first three quarters of 2023 amounted to ¥461,553,959.80, an increase from ¥396,959,203.55 in the same period of 2022, reflecting a growth of approximately 16.3%[18]. - The company has not disclosed any new product developments or market expansion strategies in this report[6]. Investment Income - The company reported a decrease in investment income from joint ventures, with a loss of ¥2,554,793.87 in the third quarter of 2023 compared to a loss of ¥117,843.63 in the same quarter of 2022[19].
安图生物(603658) - 2023 Q3 - 季度财报